{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:25:52Z","timestamp":1781018752093,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jcyt.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T08:54:54Z","timestamp":1545900894000},"page":"148-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells"],"prefix":"10.1016","volume":"21","author":[{"given":"VAMSEE D.","family":"Myneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IAN","family":"MCCLAIN-CALDWELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL","family":"MARTIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-547X","authenticated-orcid":false,"given":"LYNN","family":"VITALE-CROSS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAROLY","family":"MARKO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSEPH M.","family":"FIRRIOLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRIAN I.","family":"LABOW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5907-4691","authenticated-orcid":false,"given":"EVA","family":"MEZEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcyt.2018.11.008_bib0001","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"Journal of cellular biochemistry"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.008_bib0002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell stem cell"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.008_bib0003","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"issue":"9419","key":"10.1016\/j.jcyt.2018.11.008_bib0004","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"9624","key":"10.1016\/j.jcyt.2018.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0006","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell death & disease"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.008_bib0007","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdermsci.2014.10.004","article-title":"Bone marrow stromal cells as immunomodulators. A primer for dermatologists","volume":"77","author":"Nemeth","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.008_bib0009","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0011","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.0900803","article-title":"Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes","volume":"183","author":"Fiorina","year":"2009","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.008_bib0012","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.0910720107","article-title":"Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma","volume":"107","author":"Nemeth","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nature medicine"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","article-title":"Bone marrow-derived mesenchymal stem cells in repair of the injured lung","volume":"33","author":"Rojas","year":"2005","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10238-010-0105-6","article-title":"Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model","volume":"11","author":"Wang","year":"2011","journal-title":"Clinical and experimental medicine"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-3083.2010.02445.x","article-title":"Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action","volume":"72","author":"Yu","year":"2010","journal-title":"Scandinavian journal of immunology"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/STROKEAHA.110.601914","article-title":"Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II","volume":"42","author":"Savitz","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.008_bib0018","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"Kebriaei","year":"2009","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/bmt.2008.316","article-title":"Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium","volume":"43","author":"von Bonin","year":"2009","journal-title":"Bone marrow transplantation"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.008_bib0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/bmt.2012.184","article-title":"Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus","volume":"48","author":"Li","year":"2013","journal-title":"Bone marrow transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.008_bib0021","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3727\/096368911X582769c","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience","volume":"22","author":"Wang","year":"2013","journal-title":"Cell transplantation"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.008_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Archives of neurology"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"The Lancet. Neurology"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2017.04.003","article-title":"Immunomodulatory properties of human placental mesenchymal stem\/stromal cells","author":"Abumaree","year":"2017","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.008_bib0025","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.4049\/jimmunol.1303461","article-title":"Functional effects of TGF-beta1 on mesenchymal stem cell mobilization in cockroach allergen-induced asthma","volume":"192","author":"Gao","year":"2014","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0026","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan","year":"2007","journal-title":"Clinical and experimental immunology"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell stem cell"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.008_bib0028","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.008_bib0029","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-018-2871-5","article-title":"Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis","volume":"374","author":"Zheng","year":"2018","journal-title":"Cell and tissue research"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152809788462635","article-title":"Treatment of inflammatory diseases with mesenchymal stem cells","volume":"8","author":"Newman","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.008_bib0032","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell stem cell"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcyt.2018.01.009","article-title":"MSCs-cells with many sides","volume":"20","author":"Le Blanc","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vetimm.2018.06.008","article-title":"Equine mesenchymal stromal cells from different tissue sources display comparable immune-related gene expression profiles in response to interferon gamma (IFN)-gamma","volume":"202","author":"Cassano","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.trim.2011.05.004","article-title":"Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response","volume":"25","author":"Han","year":"2011","journal-title":"Transplant immunology"},{"issue":"Suppl 2","key":"10.1016\/j.jcyt.2018.11.008_bib0036","doi-asserted-by":"crossref","first-page":"ii29","DOI":"10.1136\/ard.61.suppl_2.ii29","article-title":"Mesenchymal stem cells. A potential source for skeletal repair","volume":"61","author":"Fibbe","year":"2002","journal-title":"Annals of the rheumatic diseases"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mechanisms of ageing and development"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0038","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.scr.2013.07.005","article-title":"Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence","volume":"11","author":"Ren","year":"2013","journal-title":"Stem Cell Res"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0039","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1194\/jlr.M030650","article-title":"Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality","volume":"54","author":"Kilpinen","year":"2013","journal-title":"Journal of lipid research"},{"issue":"8","key":"10.1016\/j.jcyt.2018.11.008_bib0040","doi-asserted-by":"crossref","first-page":"e42908","DOI":"10.1371\/journal.pone.0042908","article-title":"A mesenchymal stromal cell gene signature for donor age","volume":"7","author":"Alves","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-10-23","article-title":"The establishment of a bank of stored clinical bone marrow stromal cell products","volume":"10","author":"Sabatino","year":"2012","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.008_bib0042","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ten.tec.2010.0149","article-title":"Comparative characterization of porcine mesenchymal stem cells derived from bone marrow extract and skin tissues","volume":"16","author":"Ock","year":"2010","journal-title":"Tissue engineering. Part C, Methods"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0043","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/ten.tec.2012.0150","article-title":"Normalized median fluorescence: an alternative flow cytometry analysis method for tracking human embryonic stem cell states during differentiation","volume":"19","author":"Chan","year":"2013","journal-title":"Tissue engineering. Part C, Methods"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0044","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bonekey.2014.80","article-title":"Generation of rodent and human osteoblasts","volume":"3","author":"Taylor","year":"2014","journal-title":"BoneKEy reports"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0045","doi-asserted-by":"crossref","first-page":"e1868","DOI":"10.1038\/cddis.2015.238","article-title":"Transglutaminase 2\u2013a novel inhibitor of adipogenesis","volume":"6","author":"Myneni","year":"2015","journal-title":"Cell death & disease"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0046","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00441-013-1564-3","article-title":"Assessing the potential of colony morphology for dissecting the CFU-F population from human bone marrow stromal cells","volume":"352","author":"Gothard","year":"2013","journal-title":"Cell and tissue research"},{"issue":"1-2","key":"10.1016\/j.jcyt.2018.11.008_bib0047","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/odi.12759","article-title":"Immunomodulatory effect of vitamin K2: Implications for bone health","volume":"24","author":"Myneni","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0048","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","article-title":"A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance","volume":"6","author":"Ketterl","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.008_bib0049","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.008_bib0050","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.008_bib0051","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bioinformatics\/btw624","article-title":"The START App: a web-based RNAseq analysis and visualization resource","volume":"33","author":"Nelson","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9581350","article-title":"Comparison of Immunomodulation Properties of Porcine Mesenchymal Stromal\/Stem Cells Derived from the Bone Marrow, Adipose Tissue, and Dermal Skin Tissue","volume":"2016","author":"Ock","year":"2016","journal-title":"Stem cells international"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0053","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.imlet.2015.05.020","article-title":"Mesenchymal stem cells and infectious diseases: Smarter than drugs","volume":"168","author":"Mezey","year":"2015","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.008_bib0054","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/wound.2014.0607","article-title":"Stem Cells in Skin Wound Healing: Are We There Yet?","volume":"5","author":"Cerqueira","year":"2016","journal-title":"Advances in Wound Care"},{"issue":"2-3","key":"10.1016\/j.jcyt.2018.11.008_bib0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trim.2011.06.007","article-title":"The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age","volume":"25","author":"Landgraf","year":"2011","journal-title":"Transplant immunology"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.008_bib0056","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","article-title":"Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages","volume":"37","author":"Kim","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2018.11.008_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archoralbio.2017.01.012","article-title":"Similarities and differences between porcine mandibular and limb bone marrow mesenchymal stem cells","volume":"77","author":"Lloyd","year":"2017","journal-title":"Arch Oral Biol"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.008_bib0058","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/dvdy.22609","article-title":"Polydactyly: how many disorders and how many genes? 2010 update","volume":"240","author":"Biesecker","year":"2011","journal-title":"Dev Dyn"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0059","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.008_bib0060","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/stem.1499","article-title":"Dynamic compaction of human mesenchymal stem\/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1)","volume":"31","author":"Bartosh","year":"2013","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"8","key":"10.1016\/j.jcyt.2018.11.008_bib0061","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ymthe.2017.06.004","article-title":"Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs","volume":"25","author":"Prockop","year":"2017","journal-title":"Mol Ther"},{"issue":"47","key":"10.1016\/j.jcyt.2018.11.008_bib0062","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.1073\/pnas.1416121111","article-title":"TSG-6 as a biomarker to predict efficacy of human mesenchymal stem\/progenitor cells (hMSCs) in modulating sterile inflammation in vivo","volume":"111","author":"Lee","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.008_bib0063","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/mt.2014.17","article-title":"Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators","volume":"22","author":"Milwid","year":"2014","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.008_bib0064","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00230182","article-title":"Characterization of new members of the pregnancy-specific beta 1-glycoprotein family","volume":"106","author":"Chan","year":"1991","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.008_bib0065","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/bi00463a030","article-title":"Characterization of cDNAs of the human pregnancy-specific beta 1-glycoprotein family, a new subfamily of the immunoglobulin gene superfamily","volume":"29","author":"Zheng","year":"1990","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.008_bib0066","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1089\/ten.tea.2010.0159","article-title":"Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor","volume":"16","author":"Najar","year":"2010","journal-title":"Tissue Eng Part A"},{"issue":"416","key":"10.1016\/j.jcyt.2018.11.008_bib0067","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918306984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918306984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:36:24Z","timestamp":1761442584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918306984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1465324918306984"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.11.008","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell and Gene Therapy.","name":"copyright","label":"Copyright"}]}}